M. Munoz, “Aprepitant, When Used with Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients with Breast Cancer: Aprepitant in Breast Cancer Outcomes”, PJHS-Lahore, vol. 7, no. 8, pp. 01–02, Aug. 2026.